Long-term combination treatment with clozapine and filgrastim in patients with clozapine-induced agranulocytosis
Authors:
- Staffan HäggSHStaffan Hägg
- Staffan RoseniusSRStaffan Rosenius
- Olav SpigsetOSOlav Spigset
- 1 May 2003
- journal article
- case report
- Published by Wolters Kluwer Health in International Clinical Psychopharmacology
- Vol. 18 (3) , 173-174
Abstract
Short-term treatment with granulocyte colony-stimulating factor has been successful in reducing the duration of clozapine-induced agranulocytosis. Long-term combination treatment with filgrastim and clozapine in patients with clozapine-induced agranulocytosis has only been described in two previous cases. We describe three patients with schizophrenia who developed granulocytopenia or agranulocytosis during treatment with clozapine and who did not respond to other antipsychotics. The patients received long-term combination treatment with clozapine and filgrastim. Using a combination treatment with filgrastim and clozapine, the psychotic symptoms were successfully controlled and no haematological complications were observed during the follow-up periods of 11, 30 and 48 months, respectively. Our cases suggest that long-term treatment with filgrastim might be a useful, but exceptional, treatment approach in patients who have developed clozapine-induced granulocytopenia or agranulocytosis.Keywords
This publication has 4 references indexed in Scilit:
- An alternative to interruption of treatment in recurrent clozapine-induced severe neutropeniaThe British Journal of Psychiatry, 2001
- Treatment of severe clozapine-induced neutropenia with granulocyte colony-stimulating factor (G-CSF)The British Journal of Psychiatry, 1998
- Recombinant human granulocyte colony‐stimulating factor (rhG‐CSF; filgrastim) treatment of clozapine‐induced agranulocytosisJournal of Internal Medicine, 1993
- Treatment of Clozapine- and Molindone-Induced Agranulocytosis with Granulocyte Colony-Stimulating FactorAnnals of Pharmacotherapy, 1993